Nizovild-M FORTE Tablets

Nizovild-M FORTE combines the DPP-4 inhibitor Vildagliptin with high-strength Metformin for effective control of Type 2 Diabetes Mellitus. This dual mechanism targets insulin regulation and glucose production for optimal glycaemic control.

Benefits:

• Dual Mechanism of Action – Improves insulin secretion & reduces glucose production.

• High-Dose Metformin – Suitable for patients needing stronger glucose-lowering effects.

• Weight Neutral – Does not cause weight gain in most patients.

• Convenient Dosing – One tablet covers both drug requirements.

Dosage:

One tablet daily or as directed by the physician, preferably with meals.

Why Cardiever?

• Focused Cardio-Diabetic Specialisation

• GMP & ISO certified manufacturing

• High-quality, effective formulations

• Trusted by healthcare professionals